Brainstorm Cell Therapeutics | BCLI - Trade Creditors


Brainstorm Cell Therapeutics reported $7.49M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Biogen USD 403.9M 45.4M Jun/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.53M 173K Mar/2026
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 20.51M 4.2M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 23.61M 9.51M Jun/2026
Mesoblast USD 33.58M 14.49M Dec/2025